Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.

CHICAGO — A novel algorithm based on the normal pancreatic response to food could represent an alternative to carbohydrate counting for premeal insulin bolusing in patients with type 1 diabetes.

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Bigfoot Biomedical is doing its part to ensure that the possibility of building a smarter diabetes management system is more than just an urban legend. The tech maker has purchased a new algorithm ...

Medical device firm Tandem Diabetes is to trial a new algorithm-based version of its leading insulin pump which can predict future blood glucose levels and automatically adjust insulin levels ...

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...

Eli Lilly, one of the Big Three insulin makers that’s had its eyes on diabetes technology for several years, is making moves to launch a new insulin pump and automated insulin delivery (AID) system in ...

Helping toddlers manage their Type 1 diabetes—typically a difficult task, due to their constant growth and development, not to mention fussiness—may now be a bit easier. The FDA has expanded its ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Medical device firm Tandem Diabetes is to trial a new algorithm-based version of its leading insulin pump which can predict future blood glucose levels and automatically adjust insulin levels ...